Bernard O, Jeny F, Uzunhan Y, Dondi E, Terfous R, Label R, Sutton A, Larghero J, Vanneaux V, Nunes H, Boncoeur E, Planès C*, Dard N*. Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signalings. Am J Physiol Lung Cell Mol Physiol. 2017 Nov 22:ajplung.00153.2017.
Uzunhan Y, Jeny F, Kambouchner M, Didier M, Bouvry D, Nunes H, Bernaudin JF, Valeyre D. The Lung in Dysregulated States of Humoral Immunity. Respiration. 2017;94(5):389-404.
Gille T, Didier M, Boubaya M, Moya L, Sutton A, Carton Z, Baran-Marszak F, Sadoun-Danino D, Israël-Biet D, Cottin V, Gagnadoux F, Crestani B, d’Ortho MP, Brillet P-Y, Valeyre D, Nunes H, Planès C. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis. Eur Respir J. 2017 Jun 8;49(6). pii: 1601934. doi: 10.1183/13993003.01934-2016. Print 2017 Jun. [IF=10.57]
Uzunhan Y, Nunes H, Jeny F, Lacroix M, Brun S, Brillet PY, Martinod E, Carette MF, Bouvry D, Charler C, Lauternier F, Planès C, Tazi A, Lortholary O, Baughman RP, Valeyre D. Chronic pulmonary aspergillosis complicating sarcoidosis: presentation, outcome, mortality, risk factors, treatment. Eur. Respir. J. 2017 Jun 15;49(6). pii: 1602396. doi: 10.1183/13993003.02396-2016. Print 2017 Jun. [IF=10.57]
Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet PY, Brauner M, Kambouchner M, Huynh S, Naccache JM, Borie R, Piquet J, Mekinian A, Virally J, Uzunhan Y, Cadranel J, Crestani B, Fain O, Lhote F, Dhote R, Saidenberg-Kermanac’h N, Rosental PA, Valeyre D, Nunes H. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017 Aug 3;50(2). pii: 1602419. doi: 10.1183/13993003.02419-2016. [IF=10.57]
Tzilas V, Valeyre D, Tzouvelekis A, Bouros D. Taking a giant step in the diagnosis of idiopathic pulmonary fibrosis. Lancet Respir Med. 2017 Nov 15. pii: S2213-2600(17)30443-5.
Debray MP, Dombret MC, Pretolani M, Thabut G, Alavoine L, Brillet PY, Taillé C, Khalil A, Chanez P, Aubier M. Radiological abnormalities following bronchial thermoplasty: is the pathophysiology understood? Eur Respir J. 2017 Dec 7;50(6).
Hommada M, Mekinian A, Brillet PY, Abad S, Larroche C, Dhôte R, Fain O, Soussan M. Aortitis in giant cell arteritis: diagnosis with FDG PET/CT and agreement with CT angiography. Autoimmun Rev. 2017 Nov;16(11):1131-1137.
Naccache JM, Cadranel J, Nunes H. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med. 2017 Feb 15;195(4):541-542. doi: 10.1164/rccm.201609-1802LE. [IF=13.20]
Nunes H, Jeny F, Bouvry D, Picard C, Bernaudin JF, Ménard C, Brillet PY, Kannengiesser C, Valeyre D, Kambouchner M. Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations. Eur Respir J. 2017 May 11;49(5). pii: 1602022. doi: 10.1183/13993003.02022-2016. Print 2017 May. [IF=10.57]
Laouafa S., Perrin-Terrin A.S., Jeton F., Elliot-Portal E., Tam R., Bodineau L., Voituron N.*, Soliz J.* (2017). Pharmacological, but not genetic, alteration of neural Epo modifies the CO2/H+ central chemosensitivity in postnatal mice. Respir Physiol and Neurobiol (in press). [IF=1.66]
Joubert F.*, Loiseau C.*, Perrin-Terrin A.S.*, Cayetanot F., Frugière A., Voituron N., Bodineau L. (2016). Key brainstem strucutres activated during hypoxic exposure in one-day-old mice highlight characteristics for modeling breathing network in premature infants. Frontiers in Physiology 7 :609.
Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases. JAMA Dermatol. JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162. [IF=5.81]
Winkler L, Lhuissier FJ, Richalet JP. Systemic blood pressure at exercise in hypoxia in hypertensive and normotensive subjects. J Hypertension 2017 Jul 12. doi:10.1097/HJH.0000000000001479.
[Epub ahead of print] PubMed PMID: 28704259. [IF=4.09]
Sesé L, Nunes H, Cottin V, carton Z, Israël-Biet D, Crestani B, Cadranel J, Wallaert B, Tazi A, Maitre B, Prévot G, Marchand-Adam S, Guillot-Dudoret S, Nardy A, Dury S, Giraud V, Juvin K, Borie R, Valeyre D, Annesi-Maesano I. Role of pollution on the natural history of idiopathic pulmonary fibrosis. Thorax 2017. (Aug 10. pii: thoraxjnl-2017-209967. doi: 10.1136/thoraxjnl-2017-209967). [Epub ahead of print] [IF=8.27]
Jeton F, Soliz J, Marchant D, Joseph V, Richalet JP, Pichon A, Voituron N. Increased ventilation in female erythropoietin-deficient mouse line is not progesterone and estrous stage-dependent. Respir Physiol Neurobiol. 2017 Jul 19. pii: S1569-9048(17)30215-X. doi: 10.1016/j.resp.2017.07.002. [Epub ahead of print]. [IF=1.66]
Hermand E, Lhuissier FJ, Richalet JP. Effect of dead space on breathing
stability at exercise in hypoxia. Respir Physiol Neurobiol. 2017 Jul29; 246:26-32. doi: 10.1016/j.resp.2017.07.008.
Juge PA, Borie R, Kannengiesser C, Gazal S, Revy P, Wemeau-Stervinou L, Debray MP, Ottaviani S, Marchand-Adam S, Nathan N, Thabut G, Richez C, Nunes H, Callebaut I, Justet A, Leulliot N, Bonnefond A, Salgado D, Richette P, Desvignes JP, Lioté H, Froguel P, Allanore Y, Sand O, Dromer C, Flipo RM, Clément A, Béroud C, Sibilia J, Coustet B, Cottin V, Boissier MC, Wallaert B, Schaeverbeke T, Dastot le Moal F, Frazier A, Ménard C, Soubrier M, Saidenberg N, Valeyre D, Amselem S; FREX consortium, Boileau C, Crestani B, Dieudé P. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. 2017 May 11;49(5). pii: 1602314. doi: 10.1183/13993003.02314-2016. Print 2017 May. [IF=10.57]
Nathan SD, Albera C, Bradford WZ, Costabel U, Glaspole I, Glassberg MK, Kardatzke DR, Daigl M, Kirchgaessler KU, Lancaster LH, Lederer DJ, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis. Lancet Respir Med. 2017 Jan;5(1):33-41. doi: 10.1016/S2213-2600(16)30326-5. Epub 2016 Nov 19. [IF=19.29]
Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, Pérard L, Bouillet L, Deroux A, Abad S, Bielefeld P, Bouvry D, André M, Noel N, Bienvenu B, Proux A, Vukusic S, Bodaghi B, Sarrot-Reynauld F, Iwaz J, Amoura Z, Broussolle C, Cacoub P, Saadoun D, Valeyre D, Sève P; Groupe Sarcoïdose Francophone. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. Semin Arthritis Rheum. 2017 Mar 8. pii: S0049-0172(16)30374-2. doi: 10.1016/j.semarthrit.2017.03.005. [Epub ahead of print]. [IF=4.50]
Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, Haroche J, Pottier C, Hie M, Mathian A, Devilliers H, Nunes H, Valeyre D, Amoura Z.Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol. 2017, 264(5):891-897. doi: 10.1007/s00415-017-8444-9. doi: 10.1007/s00415-017-8444-9. [Epub ahead of print] [IF=7.35]
Patout M, Sesé L, Gille T, Coiffard B, Korzeniewski S, Lhuillier E, Pradel A, Tardif C, Chambellan A, Straus C, Matecki S, Perez T, Thiberville L, Didier A. Does training respiratory physicians in clinical respiratory physiology and interpretation of pulmonary function tests improve core knowledge? Thorax. 2017 Mar 3. pii: thoraxjnl-2016-209136. doi: 10.1136/thoraxjnl-2016-209136. [Epub ahead of print]. [IF=8.27]
Boucly A, Cottin V*, Nunes H*, Jais X, Tazi A, Prevot G, Reynaud-Gaubert M, Dromer C, Viacroze C, Hoeau-Langlard D, Pison C, Bergot E, Travlet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. Accepted in Eur Respir J, August 2017 [IF=10.57].
Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA, on behalf of the INJOURNEY™ trial investigators. Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis: results of the INJOURNEY trial. Accepted in Am J Respir Crit Care Med August 2017. [IF=13.20].
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium. Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug. [IF=10.57].
Matarazzo V, Caccialupi L, Schaller F, Shvarev Y, Kourdougli N, Bertoni A, Menuet C, Voituron N, Deneris E, Gaspar P, Bezin L, Durbec P, Hilaire G, Muscatelli F. Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi Syndrome. Accepté pour publication dans e-Life (octobre 2017).
